Department of Health and Human Services March 26, 2019 – Federal Register Recent Federal Regulation Documents

Announcement of the Renewal of the Charter for the Advisory Panel on Outreach and Education (APOE) and the April 10, 2019 Meeting of APOE
Document Number: 2019-05764
Type: Notice
Date: 2019-03-26
Agency: Centers for Medicare & Medicaid Services, Department of Health and Human Services
This notice announces the renewal of the Charter and the next meeting of the APOE (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning the Health Insurance Marketplace\SM\, Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). This meeting is open to the public.
Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research; Guidance for Industry; Availability
Document Number: 2019-05760
Type: Notice
Date: 2019-03-26
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled ``Standards Development and the Use of Standards in Regulatory Submissions Reviewed in the Center for Biologics Evaluation and Research; Guidance for Industry.'' The guidance document provides the recommendations of the Center for Biologics Evaluation and Research (CBER) on the use of standards in product development and control as well as the use of such standards in CBER's managed review process. CBER recognizes the value of standards and encourages the use of appropriate standards in the development and control of CBER-regulated medical products. Sponsors' use of standards can facilitate product development and provide a more efficient evaluation of regulatory submissions. The guidance announced in this notice finalizes the draft guidance of the same title dated December 2017.
Agency Information Collection Activities; Proposed Collection; Comment Request; Clinical Laboratory Improvement Amendments Waiver Applications
Document Number: 2019-05759
Type: Notice
Date: 2019-03-26
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on collections of information associated with Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications.
Agency Information Collection Activities; Proposed Collection; Comment Request; Prevention of Salmonella Enteritidis in Shell Eggs During Production; Recordkeeping and Registration Provisions
Document Number: 2019-05757
Type: Notice
Date: 2019-03-26
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's recordkeeping and registration requirements for shell egg producers.
Solicitation of Nominations for Appointment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
Document Number: 2019-05751
Type: Notice
Date: 2019-03-26
Agency: Department of Health and Human Services
The U.S. Department of Health and Human Services (HHS) is soliciting nominations of individuals who are interested in being considered for appointment to the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (Advisory Council) as a voting member or as a non-voting liaison representative member from an organization and/or interest group. Nominations from qualified individuals who wish to be considered for appointment to either member category of the Advisory Council are currently being accepted.
Submission for OMB Review; Comment Request
Document Number: 2019-05743
Type: Notice
Date: 2019-03-26
Agency: Department of Health and Human Services, Administration for Children and Families
Submission for OMB Review; Comment Request
Document Number: 2019-05738
Type: Notice
Date: 2019-03-26
Agency: Department of Health and Human Services, Administration for Children and Families
Submission for OMB Review; Comment Request
Document Number: 2019-05737
Type: Notice
Date: 2019-03-26
Agency: Department of Health and Human Services, Administration for Children and Families
Meeting of the Advisory Committee on Blood and Tissue Safety and Availability; Amendment
Document Number: 2019-05716
Type: Notice
Date: 2019-03-26
Agency: Department of Health and Human Services
A notice was published in the Federal Register on Monday, March 11, 2019 (Vol. 84, No. 47, pages 8731-8732), to give notice that the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) will hold a meeting on April 15-16, 2019. The notice is being amended to include a registration link for any individuals who wish to attend the meeting in-person, as well as a link to the ACBTSA website for more information.
World Trade Center Health Program; Petition 021-Deep Vein Thrombosis and Pulmonary Embolism; Finding of Insufficient Evidence
Document Number: 2019-05690
Type: Proposed Rule
Date: 2019-03-26
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
On November 28, 2018, the Administrator of the World Trade Center (WTC) Health Program received a petition (Petition 021) to add ``multiple deep vein thrombosis and pulmonary embolism'' to the List of WTC-Related Health Conditions (List). Upon reviewing the scientific and medical literature, including information provided by the petitioner, the Administrator has determined that the available evidence does not have the potential to provide a basis for a decision on whether to add deep vein thrombosis or pulmonary embolism to the List. The Administrator also finds that insufficient evidence exists to request a recommendation of the WTC Health Program Scientific/Technical Advisory Committee (STAC), to publish a proposed rule, or to publish a determination not to publish a proposed rule.
Center for Scientific Review; Notice of Closed Meeting
Document Number: 2019-05673
Type: Notice
Date: 2019-03-26
Agency: Department of Health and Human Services, National Institutes of Health
Head Start Service Duration Requirements
Document Number: 2019-05363
Type: Proposed Rule
Date: 2019-03-26
Agency: Department of Health and Human Services, Administration for Children and Families
The Office of Head Start currently requires Head Start programs to operate 100-percent of their preschool center-based slots for 1,020 annual hours by August 1, 2021, which would substantially increase the minimum amount of time preschool children must receive Head Start services. We believe the approach to require all center- based programs to increase their hours of operation was too prescriptive and will reduce grant recipients' flexibility to meet the needs of the communities they serve. It would be costly for grantees to meet the increased service-duration requirement and would likely result in a reduction in the number of children served by Head Start. For these reasons, we propose to remove the 100-percent service duration requirement from the HSPPS. We also propose technical changes to our Program Structure regulations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.